Daily Bulletin

Men's Weekly

.

Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy

  • Written by PR Newswire Asia - Daily Bulletin Au RSS
Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System Atrophy

MELBOURNE, Australia and SAN FRANCISCO, July 6, 2022 /PRNewswire/ -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced the first patient has been dosed in the Company's Phase 2 clinical trial...

Read more: Alterity Therapeutics Doses First Patient in ATH434 Phase 2 Clinical Trial in Multiple System...

More Articles ...

  1. US FDA AWARDS RARE PEDIATRIC DISEASE DESIGNATION (RPDD) TO PAXALISIB FOR AT/RT, A RARE FORM OF CHILDHOOD BRAIN CANCER
  2. harrison.ai and Sonic Healthcare join forces to launch 'franklin.ai', bringing Artificial Intelligence (AI) to pathology
  3. MetService Substantially Drive Viewable Inventory for Advertisers With IAS's Publisher Verification Solution
  4. Automation Anywhere Ranked #1 for Public Cloud RPA Market Share by Leading Analyst Firm
  5. THE WORLD'S 50 BEST RESTAURANTS UNVEILS THE 51-100 LIST FOR 2022
  6. Digital Nomads Hq Has Hit an All-time High in Growth and Acquisition of New Business Partnerships
  7. Breakthrough radiology AI provider annalise.ai appoints proven global healthcare leader as CEO, officially launches US team following FDA clearances
  8. Mitrade awarded twice at Forex Broker Award 2022
  9. Online lottery messenger service theLotter expands into Australia
  10. Appian appoints Peter Nicholson as Head of Australia and Asia

Business News

Why Careers In The Defence Industry Are Growing Rapidly

The defence sector has evolved far beyond traditional roles, opening doors to a wide range of opportunities across technology, engineering, intelligence, and operations. This is where defense industry...

Daily Bulletin - avatar Daily Bulletin

Strategic partnerships to enable global acceleration for Aussie fashion brands: SHEIN Xcelerator launches

SHEIN Xcelerator is introducing a more agile, demand-led operating model, allowing brands to scale while retaining control over creative direction and identity. For fashion brands, the pressure t...

Daily Bulletin - avatar Daily Bulletin

Tips for Avoiding Probate Delays

Probate can be a lengthy process at the best of times, and delays often compound the stress that comes with managing a loved one's estate. Many of those delays are avoidable with the right preparati...

Daily Bulletin - avatar Daily Bulletin